Review: taking Carbamazepine and Mirtazapine together


Summary

Drug interactions are reported among people who take Carbamazepine and Mirtazapine together. This review analyzes the effectiveness and drug interactions between Carbamazepine and Mirtazapine. It is created by eHealthMe based on reports of 672 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Carbamazepine

Carbamazepine has active ingredients of carbamazepine. It is often used in epilepsy. (latest outcomes from Carbamazepine 21,596 users)

Mirtazapine

Mirtazapine has active ingredients of mirtazapine. It is often used in depression. (latest outcomes from Mirtazapine 27,373 users)

On Sep, 19, 2016

672 people who take Carbamazepine, Mirtazapine are studied.


Number of reports submitted per year:

Carbamazepine and Mirtazapine drug interactions.

Drug effectiveness over time:

Carbamazepine:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 25.0% - (1 of 4 people)
  • 6 - 12 months: 50.0% - (1 of 2 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 2 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 100.0% - (6 of 6 people)
  • not specified: 0.0% - (0 of 0 people)
Mirtazapine:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 40.0% - (2 of 5 people)
  • 6 - 12 months: 0.0% - (0 of 2 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 33.0% - (1 of 3 people)
  • 5 - 10 years: 33.0% - (1 of 3 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Carbamazepine:
  • female: 58.0% - (7 of 12 people)
  • male: 50.0% - (2 of 4 people)
Mirtazapine:
  • female: 25.0% - (3 of 12 people)
  • male: 50.0% - (2 of 4 people)

Drug effectiveness by age:

Carbamazepine:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 33.0% - (1 of 3 people)
  • 40-49: 50.0% - (2 of 4 people)
  • 50-59: 100.0% - (5 of 5 people)
  • 60+: 0.0% - (0 of 3 people)
Mirtazapine:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 25.0% - (1 of 4 people)
  • 40-49: 25.0% - (1 of 4 people)
  • 50-59: 25.0% - (1 of 4 people)
  • 60+: 33.0% - (1 of 3 people)

Most common drug interactions over time *:

< 1 month:
  • confusional state
  • drug abuse
  • intentional overdose
  • sopor
  • somnolence
  • intentional self-injury
  • suicide attempt
  • epilepsy
  • blood creatine phosphokinase increased
  • drug ineffective
1 - 6 months:
  • anxiety
  • coronary artery disease
  • neutropenia
  • rash
  • type 2 diabetes mellitus
  • amnestic disorder
  • bruxism
  • cardiac disorder
  • dystonia
  • gastrooesophageal reflux disease
6 - 12 months:
  • aggression aggravated
  • agitation
  • anxiety aggravated
  • arteriosclerosis
  • compulsions
  • disinhibition
  • dyskinesia
  • euphoric mood
  • gambling
  • mania
1 - 2 years:
  • coronary artery disease
  • movement disorder
  • multiple sclerosis
  • tardive dyskinesia
  • type 2 diabetes mellitus
  • blister
  • erythema multiforme
  • stevens-johnson syndrome
2 - 5 years:
  • completed suicide
  • detoxification
  • dizziness
  • drug ineffective
  • pain
  • drug dependence
  • malignant urinary tract neoplasm
  • paraesthesia
  • syncope
  • overdose
5 - 10 years:
  • diabetes mellitus
  • diabetic gastroparesis
  • glucose tolerance impaired
  • hyperglycaemia
  • hyperlipidaemia
  • neuropathy peripheral
  • type 2 diabetes mellitus
  • asthma
  • blood cholesterol increased
  • blood triglycerides increased
10+ years:
  • hepatic failure
  • sick sinus syndrome
  • hypernatraemia
  • lack of strength, muscle weakness, weakness
  • urinary incontinence
not specified:
  • weight increased
  • type 2 diabetes mellitus
  • nausea
  • asthenia
  • vomiting
  • fatigue
  • blood cholesterol increased
  • depression
  • anxiety
  • pain

Most common drug interactions by gender *:

female:
  • type 2 diabetes mellitus
  • weight increased
  • blood cholesterol increased
  • bipolar disorder
  • blood triglycerides increased
  • nausea
  • depression
  • headache
  • pain
  • hypertension
male:
  • fatigue
  • weight decreased
  • constipation
  • asthenia
  • vomiting
  • suicidal ideation
  • muscle spasms
  • back pain
  • anxiety
  • diarrhoea

Most common drug interactions by age *:

0-1:
  • diabetic complication
  • pancreatitis
  • pancreatitis chronic
2-9:
  • medulloblastoma
  • maternal drugs affecting foetus
  • hydrocephalus
  • congenital hydrocephalus
  • emotional disorder
  • tardive dyskinesia
  • alopecia
  • blindness
  • blood chloride decreased
  • coma
10-19:
  • headache
  • rectal haemorrhage
  • abdominal pain
  • abdominal pain upper
  • adnexa uteri pain
  • amenorrhoea
  • arthralgia
  • biliary dyskinesia
  • chills
  • cholecystitis
20-29:
  • epilepsy
  • suicidal ideation
  • convulsion
  • depression
  • diabetes mellitus inadequate control
  • drug withdrawal syndrome
  • paraesthesia
  • type 2 diabetes mellitus
  • aggression
  • back pain
30-39:
  • weight increased
  • type 2 diabetes mellitus
  • blood cholesterol increased
  • bipolar disorder
  • blood triglycerides increased
  • depression
  • vision blurred
  • dizziness
  • dysarthria
  • nausea
40-49:
  • completed suicide
  • type 2 diabetes mellitus
  • asthenia
  • diabetes mellitus
  • nausea
  • somnolence
  • depression
  • chest pain
  • electrocardiogram qt prolonged
  • pain
50-59:
  • diarrhoea
  • vomiting
  • weight decreased
  • fatigue
  • asthenia
  • abdominal pain upper
  • constipation
  • muscle spasms
  • abdominal distension
  • dysuria
60+:
  • fall
  • confusional state
  • anxiety
  • vomiting
  • chronic obstructive pulmonary disease
  • pain
  • pain in extremity
  • balance disorder
  • coronary artery disease
  • pneumonia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Carbamazepine and Mirtazapine?

Can you answer these questions?

More questions for: Carbamazepine, Mirtazapine

You may be interested in these reviews

More reviews for: Carbamazepine, Mirtazapine

On eHealthMe, Carbamazepine (carbamazepine) is often used to treat epilepsy. Mirtazapine (mirtazapine) is often used to treat depression. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.